《化疗药物与线粒体功能障碍：聚焦阿霉素、曲妥珠单抗和舒尼替尼》勘误
Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib".
作者信息
Gorini Stefania, De Angelis Antonella, Berrino Liberato, Malara Natalia, Rosano Giuseppe, Ferraro Elisabetta
机构信息
Laboratory of Pathophysiology of Cachexia and Metabolism of Skeletal Muscle, IRCCS San Raffaele Pisana, 00166 Rome, Italy.
Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
出版信息
Oxid Med Cell Longev. 2019 Jun 26;2019:9601435. doi: 10.1155/2019/9601435. eCollection 2019.
Abstract
[This corrects the article DOI: 10.1155/2018/7582730.].
摘要
[本文更正文章DOI：10.1155/2018/7582730。]
相似文献
1
Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib".《化疗药物与线粒体功能障碍：聚焦阿霉素、曲妥珠单抗和舒尼替尼》勘误
Oxid Med Cell Longev. 2019 Jun 26;2019:9601435. doi: 10.1155/2019/9601435. eCollection 2019.
2
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib.化疗药物与线粒体功能障碍：以多柔比星、曲妥珠单抗和舒尼替尼为例。
Oxid Med Cell Longev. 2018 Mar 18;2018:7582730. doi: 10.1155/2018/7582730. eCollection 2018.
3
Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.曲妥珠单抗和化疗药物对胃癌细胞系的生长抑制作用。
Cancer Lett. 2004 Oct 28;214(2):215-24. doi: 10.1016/j.canlet.2004.04.029.
4
Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.给予心脏保护药物对乳腺癌细胞治疗反应的影响。
Anticancer Res. 2016 Jan;36(1):87-93.
5
Corrigendum to "Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer".《曲妥珠单抗耐药胃癌潜在关键基因的生物信息学分析》勘误
Dis Markers. 2020 Dec 24;2020:3147825. doi: 10.1155/2020/3147825. eCollection 2020.
6
Corrigendum to "Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis".《富氢盐水通过抑制炎症和凋亡减轻阿霉素大鼠模型中的心脏和肝脏损伤》勘误
Mediators Inflamm. 2017;2017:3675910. doi: 10.1155/2017/3675910. Epub 2017 Oct 17.
7
Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction.基线免疫球蛋白E水平作为多柔比星和曲妥珠单抗相关心脏功能障碍的标志物
Circ Res. 2016 Oct 28;119(10):1135-1144. doi: 10.1161/CIRCRESAHA.116.309004. Epub 2016 Aug 31.
8
An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer.舒尼替尼联合多西他赛和曲妥珠单抗一线治疗人表皮生长因子受体 2 阳性转移性乳腺癌的探索性研究。
Breast. 2012 Dec;21(6):716-23. doi: 10.1016/j.breast.2012.09.002. Epub 2012 Sep 27.
9
Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells Autophagy and Death Receptor Signaling.勘误：GZ17 - 6.02与多柔比星相互作用以杀死肉瘤细胞：自噬与死亡受体信号传导。
Front Oncol. 2021 Apr 16;11:677725. doi: 10.3389/fonc.2021.677725. eCollection 2021.
10
Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy.组织多普勒和应变率成像在早期检测曲妥珠单抗和蒽环类药物介导的心肌病中的应用价值。
J Am Soc Echocardiogr. 2009 Apr;22(4):418-24. doi: 10.1016/j.echo.2009.01.016. Epub 2009 Mar 9.
引用本文的文献
1
Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control: Novel Therapeutic Target.蒽环类药物心脏毒性诱导心肌代谢和线粒体质量控制的渐进性变化：新的治疗靶点。
JACC CardioOncol. 2024 Apr 16;6(2):217-232. doi: 10.1016/j.jaccao.2024.02.005. eCollection 2024 Apr.
2
The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review.黄酮类化合物作为一种对抗多柔比星诱导的心脏毒性的心脏保护策略的作用：综述。
Molecules. 2022 Feb 15;27(4):1320. doi: 10.3390/molecules27041320.
3
The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells.脂肪细胞对多柔比星处理的三阴性乳腺癌细胞脂代谢的旁分泌作用。
Adipocyte. 2021 Dec;10(1):505-523. doi: 10.1080/21623945.2021.1979758.
本文引用的文献
1
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib.化疗药物与线粒体功能障碍：以多柔比星、曲妥珠单抗和舒尼替尼为例。
Oxid Med Cell Longev. 2018 Mar 18;2018:7582730. doi: 10.1155/2018/7582730. eCollection 2018.
Zotero 插件